A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia.

Authors:
Tanaka Y.

Journal:
Inflamm Regen

Publication Year: 2023

DOI:
10.1186/s41232-022-00253-3

PMCID:
PMC9826760

PMID:
36617565

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Inflamm Regen

Abbreviation: Inflamm Regen

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Mutual interaction of neurons and astrocytes derived from iPSCs with APP V717L mutation developed t…
Supakul S; Murakami R; Oyama C and 7 more (2024) - Transparency Score: 3/6
The gateway reflex regulates tissue-specific autoimmune diseases.
Tanaka Y; Ohki I; Murakami K and 3 more (2024) - Transparency Score: 3/6
The gut-liver axis in hepatobiliary diseases.
Ichikawa M; Okada H; Nakamoto N and 3 more (2024) - Transparency Score: 3/6
Accelerating corneal wound healing using exosome-mediated targeting of NF-κB c-Rel.
Zhao W; He X; Liu R and 1 more (2023) - Transparency Score: 3/6
A disease-specific iPS cell resource for studying rare and intractable diseases.
Saito MK; Osawa M; Tsuchida N and 8 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable Consent for publicationNot applicable Competing interestsY. Tanaka has received speaking fees and/or honoraria from Behringer-Ingelheim, Eli Lilly, Abbvie, Gilead, AstraZeneca, Bristol-Myers, Chugai, Daiichi-Sankyo, Eisai, Pfizer, Mitsubishi-Tanabe, GlaxoSmithKline, received research grants from Asahi-Kasei, Abbvie, Chugai, Eisai, Takeda, Daiichi-Sankyo, Behringer-Ingelheim. Competing interests Y. Tanaka has received speaking fees and/or honoraria from Behringer-Ingelheim, Eli Lilly, Abbvie, Gilead, AstraZeneca, Bristol-Myers, Chugai, Daiichi-Sankyo, Eisai, Pfizer, Mitsubishi-Tanabe, GlaxoSmithKline, received research grants from Asahi-Kasei, Abbvie, Chugai, Eisai, Takeda, Daiichi-Sankyo, Behringer-Ingelheim."

Evidence found in paper:

"Funding This paper is not funded."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025